RNS Number : 5717O
Conygar Investment Company PLC(The)
03 October 2023
 

THIS ANNOUNCEMENT AND THE INFORMATION CONTAINED IN IT ARE NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN WHOLE OR IN PART, IN OR INTO OR FROM THE UNITED STATES, CANADA, AUSTRALIA, NEW ZEALAND, THE REPUBLIC OF SOUTH AFRICA, JAPAN OR ANY MEMBER STATE OF THE EUROPEAN ECONOMIC AREA OR ANY OTHER JURISDICTION WHERE TO DO SO MIGHT CONSTITUTE A VIOLATION OF LOCAL APPLICABLE SECURITIES LAWS OR REGULATIONS.

 

PLEASE SEE THE SECTION ENTITLED "IMPORTANT NOTICE" TOWARDS THE END OF THIS ANNOUNCEMENT.

 

3 October 2023

 

The Conygar Investment Company PLC (the "Company")

Conygar ZDP PLC (the "Issuer")

 

Publication of ZDP Listing Document

Further to the announcement on 2 October 2023 regarding the issue of 15 million zero dividend preference shares ("ZDP Shares"), the boards of the Issuer and the Company announce that they have today published a Listing Document (the "Listing Document") approved by The International Stock Exchange Authority.

The ZDP Shares are expected to be admitted to the Official List of the International Stock Exchange at 8.00a.m. on 4 October 2023.

A copy of the Listing Document will shortly be available for inspection on the Company's website: www.conygar.com. Capitalised terms used and not defined in this announcement bear the meanings given to them in the Listing Document.

 

 

Enquiries:

 

The Conygar Investment Company PLC

+44 (0) 20 7258 8670

Robert Ware / David Baldwin

 


Liberum Capital Limited

Financial Adviser and Sole Bookrunner

 

 

 

Nominated Adviser and Broker

 

+44 (0)20 3100 2000

Chris Clarke / Darren Vickers / Owen Matthews / Will King

 

+44 (0)20 3100 2185

Richard Lindley /Jamie Richards

 


Temple Bar Advisory (Public Relations)

+44 (0)7795 425580

Alex Child-Villiers

 

+44 (0)7827 960151

Will Barker 

 


 

IMPORTANT NOTICE

 

Liberum, which is a member of the London Stock Exchange, is authorised and regulated in the UK by the FCA and is acting exclusively for the Issuer and the Company in connection with the Issue, Admission and any other matter referred to in this announcement. Liberum will not regard any other person as its client in relation to the Issue, Admission or any other transaction or arrangement referred to in this announcement and will not be responsible to anyone other than the Issuer and the Company for providing the protections afforded to its clients or for providing any advice in relation to the Issue, Admission or any other transaction or arrangement referred to in this announcement.

 

Apart from the responsibilities and liabilities, if any, which may be imposed on Liberum by FSMA or the regulatory regime established thereunder, Liberum does not make any representation, express or implied, in relation to, nor accepts any responsibility whatsoever for, the contents of this announcement or any other statement made or purported to be made by it or on its behalf in connection with the Issuer, the Company, the ZDP Shares, the Issue, Admission or any other transaction or arrangement referred to in this announcement, and nothing in this announcement is or shall be relied upon as a promise or representation in this respect, whether as to the past or future. Liberum and its affiliates accordingly, to the fullest extent permissible by law, disclaim all and any responsibility or liability (save for any statutory liability) whether arising in tort, contract or otherwise which it or they might otherwise have to any person, other than the Issuer and the Company, in respect of this announcement or any such statement.

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCEXLFBXBLFFBX